← All companies

ICCC

ImmuCell Corporation

ICCC Nasdaq In Vitro & In Vivo Diagnostic Substances EDGAR ↗

$11.04

-0.02 -0.18%

Key statistics

from XBRL data in SEC filings

Market cap

$99.9M

Revenue (TTM)

$29.9M

Net income (TTM)

-$545K

EPS (TTM)

$-0.07

P/E ratio

—

Dividend yield

—

Free cash flow

$1.22M

Cash

$6.81M

Total assets

$44.1M

Gross margin

42.6%

52-week range

$4.52 – $12.10

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Results of operations (earnings release) Jul 9, 2026 8-K Shareholder vote results Jun 17, 2026 8-K Regulation FD disclosure Jun 10, 2026 8-K Results of operations (earnings release) May 14, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 10-K/A Fiscal year ended 2025-12-31 May 13, 2026 8-K Entered a material agreement May 8, 2026 8-K Director or officer change; Other events Apr 14, 2026 8-K Results of operations (earnings release) Apr 8, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Director or officer change Mar 18, 2026 8-K Results of operations (earnings release) Mar 4, 2026 8-K Director or officer change Feb 9, 2026 8-K Entered a material agreement; Director or officer change Feb 2, 2026 8-K Results of operations (earnings release); Material impairment; Other events Jan 8, 2026 8-K Material impairment; Other events Dec 29, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Director or officer change Nov 4, 2025 8-K Results of operations (earnings release) Oct 7, 2025 8-K Entered a material agreement; Director or officer change Sep 30, 2025 8-K Entered a material agreement; Took on a direct financial obligation Aug 25, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Entered a material agreement; Took on a direct financial obligation Aug 12, 2025 8-K Results of operations (earnings release) Jul 9, 2025 8-K Other events Jun 25, 2025 8-K Shareholder vote results Jun 17, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Results of operations (earnings release) Apr 8, 2025 8-K Entered a material agreement; Director or officer change Apr 7, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 8-K Results of operations (earnings release) Feb 25, 2025 8-K Other events Jan 16, 2025 8-K Results of operations (earnings release) Jan 10, 2025 8-K Entered a material agreement; Terminated a material agreement; Director or officer change Dec 9, 2024 8-K Entered a material agreement Dec 2, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024